CD1D and neoplasm: iNKT cell activation can occur via multiple mechanisms—either indirectly, through cytokines or CD1d+ antigen-presenting cells (APCs) such as dendritic cells (DCs), macrophages, or B cells, or directly, by recognition of tumor-associated glycolipid antigens presented by CD1d-expressing tumor cells [113–117] (Fig. 3A).